ConductScience.org, home

Paper26367232

Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.

Naples JC and 7 others. Bone Marrow Transplant, 2016. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children. Papers, record 26367232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26367232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2016
PubMed
Publication types
Letter
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Naples JCJ C
2Skeens MAM A
3Auletta JJ
4Rangarajan HH
5Abu-Arja RR
6Horwitz EE
7Stanek JJ
8Bajwa RSR S

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
Hepatic Veno-Occlusive DiseaseMajor topic
Adolescent
Allografts
Autografts
Child
Child, Preschool
Female
Humans
Infant
Male

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131214465Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.J Pediatr Intensive Care2014https://conductscience.org/library/papers/31214465PubMed
222780209Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.Expert Rev Hematol2012https://conductscience.org/library/papers/22780209PubMed
317994121Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.Bone Marrow Transplant2008https://conductscience.org/library/papers/17994121PubMed
425300869Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/25300869PubMed
512134100Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease.Transplantation2002https://conductscience.org/library/papers/12134100PubMed
68355040Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.J Clin Oncol1993https://conductscience.org/library/papers/8355040PubMed
725401997How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation.Br J Haematol2015https://conductscience.org/library/papers/25401997PubMed
86363247Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.Hepatology1984https://conductscience.org/library/papers/6363247PubMed
920167278Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/20167278PubMed
1019766729Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19766729PubMed
1114661036Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.Bone Marrow Transplant2004https://conductscience.org/library/papers/14661036PubMed
123321587Venoocclusive disease of the liver following bone marrow transplantation.Transplantation1987https://conductscience.org/library/papers/3321587PubMed

Download CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41530538
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant2026https://conductscience.org/library/papers/41530538PubMed
41035660Results From a UK Consensus via Delphi on Practical Considerations Surrounding Risk Assessment and Patient Monitoring for a Prompt Diagnosis of Severe Veno-Occlusive Disease (VOD) in Adults Post-HSCT.EJHaem2025https://conductscience.org/library/papers/41035660PubMed
40144213Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations.Front Oncol2025https://conductscience.org/library/papers/40144213PubMed
34909973Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.Einstein (Sao Paulo)2021https://conductscience.org/library/papers/34909973PubMed
34666352Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.Blood Adv2022https://conductscience.org/library/papers/34666352PubMed
33219341Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.Bone Marrow Transplant2021https://conductscience.org/library/papers/33219341PubMed
32665674Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading.Bone Marrow Transplant2021https://conductscience.org/library/papers/32665674PubMed
32398785Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? : Prospective evaluation of pediatric EBMT criteria for VOD.Bone Marrow Transplant2020https://conductscience.org/library/papers/32398785PubMed
32318059Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol2020https://conductscience.org/library/papers/32318059PubMed
30933024Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children.J Pediatr Hematol Oncol2019https://conductscience.org/library/papers/30933024PubMed
30683907Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome.Bone Marrow Transplant2019https://conductscience.org/library/papers/30683907PubMed
30302228Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure.Int J Hematol Oncol2017https://conductscience.org/library/papers/30302228PubMed
28759025Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.Bone Marrow Transplant2018https://conductscience.org/library/papers/28759025PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26367232

GET https://conductscience.org/api/papers/v1/26367232/authors